{
    "nctId": "NCT02611557",
    "briefTitle": "Lymphedema Progression Screening Using MRI",
    "officialTitle": "Imaging Noninvasively With Functional-MRI for Onset, Response and Management of Lymphatic Impairment",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Lymphedema progression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* sex=female\n* age=40-70 yrs\n* clinical diagnosis of lymphedema secondary to breast cancer treatment (including node dissection, radiation therapy, and/or sentinel node biopsy).\n\nExclusion Criteria:\n\n* Contraindication to MRI\n* Bilateral axillary lymph node removal\n* Primary lymphedema. Individuals on tyrosine kinase inhibitors or calcium channel blockers",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}